Taro recalls skin treatment cream from US, Puerto Rico markets
- PM Narendra Modi calls meeting to review 'Most Favoured Nation' status to Pakistan
- BK Bansal, senior bureaucrat, commits suicide along with son at his Delhi residence
- US presidential debate: Trump, Hillary Clinton deny their own words
- Nine out of ten people in world breathing polluted air: WHO
- Behind the voices at Maratha rallies, an anti-Dalit tone
Taro Pharmaceuticals, the Israel -based subsidiary of Sun Pharmaceuticals, has recalled nearly 40,000 tubes of Fluorouracil topical cream, used to treat various skin conditions, from the American market.
Taro Pharmaceuticals USA Inc has voluntarily recalled 39,982 tubes of Fluorouracil Topical Cream USP from the US and Puerto Rico markets, US Food and Drug Administration (USFDA) said in its enforcement report.
The reason for the class II recall is that 'product lacks stability', it added.
As per the USFDA, class II recalls are done in a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Sun Pharma had acquired a controlling stake in Taro in September, 2010. The Mumbai-based firm currently holds 66.5 per cent stake in Taro.
- Power struggle within weakens Samajwadi Party already undergoing an identity crisis in UP
- Preventive detention is being routinised as an instrument of state repression
- The challenge of garbage is set to grow, solid waste management plans need to be implemented
- After Uri, a replay of a 2001 predicament
- Any response to Uri must factor in Pakistani state’s relationship with non-state actors
- It is assumed that Blacks will vote 93 per cent for Clinton, seven per cent for Trump